Status:
COMPLETED
Efficacy of Coadministration of Calcitonin and Hyperbaric Bupivacaine in Spinal Anesthesia in Tramadol-abuse Patients
Lead Sponsor:
Ain Shams University
Conditions:
Analgesia
Eligibility:
All Genders
18-60 years
Phase:
PHASE4
Brief Summary
Increasing duration of local anesthetic action is desired for prolongation of postoperative patient comfort, as well as decreasing perioperative opioid consumption and subsequent side effects. Calcito...
Eligibility Criteria
Inclusion
- Patients with history of tramadol addiction (single drug addiction) and duration of addiction \>1 year
- Elective lower abdomen or lower extremities surgeries under spinal anesthesia
- ASA physical status I and II
Exclusion
- Patient's refusal,
- duration of surgery more than 120 min,
- obesity with body mass index (BMI) \>35 kg/m2,
- generalized infection or localized infection at level of blockade,
- neurological disease,
- psychological disorder
- coagulation disorder,
- history of uncontrolled hypertension,
- history of uncontrolled blood sugar,
- allergy to bupivacaine or calcitonin
Key Trial Info
Start Date :
September 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 31 2021
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT04445857
Start Date
September 1 2020
End Date
January 31 2021
Last Update
April 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ain-Shams University Hospitals
Cairo, Egypt